WIDE MOAT STOCKS COMPARISON

Checking

 

Stock Comparison

Abbott Laboratories vs Halma plc

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Abbott Laboratories

ABT · New York Stock Exchange

Market cap (USD)$191.3B
Gross margin (TTM)52.1%
Operating margin (TTM)13.8%
Net margin (TTM)9.7%
SectorHealthcare
IndustryMedical devices
CountryUS
Data as of2026-08-23
22/100
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Abbott Laboratories's moat claims, evidence, and risks.

View ABT analysis

Halma plc

HLMA · London Stock Exchange

Market cap (USD)$17.7B
Gross margin (TTM)—
Operating margin (TTM)20.4%
Net margin (TTM)14.4%
SectorTechnology
IndustryIndustrial conglomerates
CountryGB
Data as of2026-08-23
Insufficient evidence
Moat score

Weighted across the company's segments.

Full stock profile

Dive deeper into Halma plc's moat claims, evidence, and risks.

View HLMA analysis

Comparison highlights

  • Segment focus: Abbott Laboratories has 9 segments (27% in Cardiovascular and Electrophysiology Devices); Halma plc has 3 segments (40.2% in Environmental & Analysis).
  • Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
  • Moat breadth: Abbott Laboratories has 1 moat types across 1 domains; Halma plc has 0 across 0.

Primary market context

Abbott Laboratories

Cardiovascular and Electrophysiology Devices

Market

Rhythm management, electrophysiology, heart failure, vascular and structural-heart devices

Geography

Global

Customer

Hospitals, ambulatory surgery centers and cardiovascular clinicians

Role

Implantable and procedure-based device manufacturer

Revenue share

27%

Halma plc

Environmental & Analysis

Market

Environmental monitoring and analysis instruments (water/resource quality, pollution monitoring) plus materials/optoelectronic analysis and photonics components

Geography

Global

Customer

Utilities and industrial operators; laboratories; OEMs; technology/data-centre customers for photonics components

Role

Instrument OEM / component supplier + solutions provider

Revenue share

40.2%

Side-by-side metrics

Abbott Laboratories
Halma plc
Ticker / Exchange
ABT - New York Stock Exchange
HLMA - London Stock Exchange
Market cap (USD)
$191.3B
$17.7B
Gross margin (TTM)
52.1%
n/a
Operating margin (TTM)
13.8%
20.4%
Net margin (TTM)
9.7%
14.4%
Sector
Healthcare
Technology
Industry
Medical devices
Industrial conglomerates
HQ country
US
GB
Primary segment
Cardiovascular and Electrophysiology Devices
Environmental & Analysis
Market structure
Oligopoly
Competitive
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
22 / 100
n/a
Moat domains
Demand
n/a
Last update
2026-09-05
2026-09-05

Moat coverage

Shared moat types

No overlap yet.

Abbott Laboratories strengths

Installed Base Consumables

Halma plc strengths

No unique moat types yet.

Segment mix

Abbott Laboratories segments

Full profile >

Established Pharmaceutical Products

Competitive

11.9%

Pediatric Nutrition

Oligopoly

8.1%

Adult Nutrition

Oligopoly

8.9%

Core Laboratory Diagnostics

Oligopoly

11.3%

Rapid and Molecular Diagnostics

Competitive

6%

Cancer Diagnostics

Competitive

7.3%

Diabetes Care (CGM and glucose monitoring)

Oligopoly

17.4%

Cardiovascular and Electrophysiology Devices

Oligopoly

27%

Neuromodulation Devices

Oligopoly

2.1%

Halma plc segments

Full profile >

Safety

Competitive

36.7%

Environmental & Analysis

Competitive

40.2%

Healthcare

Competitive

23.2%

Act on this comparison

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.